re: support building - 70% controle rate!!
Looks great
Twenty (20) subjects received a combination of PXD + cisplatin and 20 patients received PXD + paclitaxel. Eighty (80) percent of subjects on combination therapy had either complete response (11%), partial response (22%), or stabilized disease (44%), providing an overall disease control rate of 77%. The PXD and cisplatin or paclitaxel combinations were well tolerated, with no unexpected toxicities encountered
NRT Price at posting:
0.0¢ Sentiment: None Disclosure: Held